Lupus miliaris disseminatus faciei (LMDF) is a rare benign dermatosis, of unknown etiology and treatment often disappointing.
Introduction
Lupus miliaris disseminatus faciei (LMDF) is a rare benign dermatosis, of unknown etiology and treatment often disappointing.
We report a new case of LMDF treated successfully with isotretinoin and injection of platelet rich plasma.
Case Report
An 18-year-old man presented with 4 months histo- the nasolabial folds, the cheeks, and the perioral areas are preferentially involved, but occasionally more widespread dissemination occurs.
Therapy is difficult with variable efficacy and several therapeutic modalities: Dapsone, doxycycline, minocycline, isotretinoin, clofazimine, isoniazid, and corticosteroids have been used to effectively induce remission [2, 3] . Topical agents like psoralen with ultraviolet A therapy (PUVA), erythromycin and metronidazole have also been used [2] . Considering LMDF a condition related to rosacea, it may be worthwhile trying oral nicomide containing nicotinamide and zinc, which has been found to be an effective therapy in rosacea [4] . Topical tacrolimus may induce rosacea like dermatitis. A non ablatif fractional 1565 nm laser was effective in one case [5] . In our case, isotretinoin was effective on the lesions of LMDF. Platelet rich plasma injections were effective on the depressive scars.
Platelet-rich plasma (PRP) which contains large amounts of growth factors seems to be effective during the wound-healing process [6] . A review showed the efficacy and safety of intradermal injection of PRP in atrophic scars [6] .
LMDF is an enigmatic entity, still controversial even though it is widely recognized. A better understanding of etiopathogenic mechanisms would improve the management of these patients, especially since there is a significant aesthetic damage. Isotretinoin and platelet rich plasma may be a useful tool in the treatment of LMDF.
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All the authors contributed for the acquisition, analysis, interpretation of data for the work; and drafting the work or revising it critically for important intellectual content; and the final approval of the version to be published; and the agreement to be accountable for all aspects of the work. search laboratory (VDRL) test was non-reactive. Biopsy from a representative skin nodule showed mild epidermal hyperplasia and granulomatous reaction pattern in the dermis. Granulomas were composed of epithelioid cells; plenty of Langhan's and foreign body giant cells surrounded by a lymphocytic cuff. Extensive caseous necrosis was seen in the center of multiple granulomas (Figure 2) . Stain for acid-fast bacilli and fungi were negative. A final diagnosis of lupus miliaris disseminatus faciei was made based on the above-mentioned features.
A trial of anti-tubercular therapy with the combination rifampin-isoniazid-pyrazinamide-ethambutol (4 tablets a day) was given for 2 months without improvement rather he had developed some new lesions on the arms. He was treated with isotretinoin 0.5 mg/kg/d. We note an improvement of the facial lesions with atrophic scars. He was treated with intradermal injection of platelet rich plasma every 4 weeks for 6 months. We note a good improvement of the scars (Figure 3 ).
LMDF typically occurs as symmetrically distributed eruptions in the center of the face [1] . The lower portions of the eyelids, the lower portions of the forehead, 
